Experimental and Molecular Medicine

  • 제49권11호
  • /
  • Pages.1.1-1.6
  • /
  • 2017
  • /
  • 1226-3613(pISSN)
  • /
  • 2092-6413(eISSN)
생화학분자생물학회 (Korean Society for Biochemistry and Molecular Biongy)
권호 표지
DOI QR코드

DOI QR Code

Lower serum extracellular superoxide dismutase levels are associated with polyneuropathy in recent-onset diabetes

  • Strom, Alexander (Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research) ;
  • Kaul, Kirti (Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research) ;
  • Bruggemann, Jutta (Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research) ;
  • Ziegler, Iris (Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research) ;
  • Rokitta, Ilka (Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research) ;
  • Puttgen, Sonja (Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research) ;
  • Szendroedi, Julia (Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research) ;
  • Mussig, Karsten (Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research) ;
  • Roden, Michael (Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research) ;
  • Ziegler, Dan (Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research) ;
  • GDS Group (The GDS Group)
  • 투고 : 2017.02.20
  • 심사 : 2017.05.02
  • 발행 : 2017.11.30
⟨ 이전 논문 다음 논문 ⟩

초록

Increased oxidative stress is implicated in the pathogenesis of experimental diabetic neuropathy, but translational evidence in recent-onset diabetes is scarce. We aimed to determine whether markers of systemic oxidative stress are associated with diabetic sensorimotor polyneuropathy (DSPN) in recent-onset diabetes. In this cross-sectional study, we measured serum concentrations of extracellular superoxide dismutase (SOD3), thiobarbituric acid reactive substances (TBARS), and reduced glutathione (GSH) in 107 type 1 and 215 type 2 diabetes patients from the German Diabetes Study baseline cohort and 37 glucose-tolerant individuals (controls). DSPN was defined by electrophysiological and clinical criteria (Toronto Consensus, 2011). SOD3 and GSH concentrations were lower in individuals with type 1 and type 2 diabetes compared with concentrations in controls (P<0.0001). In contrast, the TBARS concentration was higher in participants with type 1 diabetes and type 2 diabetes compared with levels in controls (P<0.0001). In addition, the SOD3 concentration was higher in participants with type 1 diabetes compared to concentrations in those with type 2 diabetes (P<0.0001). A low SOD3 concentration was associated with DSPN in individuals with type 1 diabetes (${\beta}=-0.306$, P = 0.002), type 2 diabetes (${\beta}=-0.164$, P = 0.017), and in both groups combined (${\beta}=-0.206$, P = 0.0003). Lower SOD3 concentrations were associated with decreased motor nerve conduction velocity (NCV) in men and, to a lesser degree, with reduced sensory NCV in women with diabetes. In conclusion, several biomarkers of oxidative stress are altered in recent-onset diabetes, with only a lower SOD3 concentration being linked to the presence of DSPN, suggesting a role for reduced extracellular antioxidative defense against superoxide in the early development of DSPN.

키워드

참고문헌

  1. Ziegler D, Papanas N, Vinik AI, Shaw JE. Epidemiology of polyneuropathy in diabetes and prediabetes. Handbook Clin Neurol 2014; 126: 3-22.
  2. Vincent AM, Callaghan BC, Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 2011; 7: 573-583. https://doi.org/10.1038/nrneurol.2011.137
  3. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995; 64: 97-112. https://doi.org/10.1146/annurev.bi.64.070195.000525
  4. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002; 33: 337-349. https://doi.org/10.1016/S0891-5849(02)00905-X
  5. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxic 2003; 17: 24-38. https://doi.org/10.1002/jbt.10058
  6. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615-1625. https://doi.org/10.2337/diabetes.54.6.1615
  7. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 2004; 25: 612-628. https://doi.org/10.1210/er.2003-0019
  8. Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 2004; 27: 2178-2183. https://doi.org/10.2337/diacare.27.9.2178
  9. Ziegler D, Buchholz S, Sohr C, Nourooz-Zadeh J, Roden M. Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients. Acta Diabetol 2015; 52: 65-72. https://doi.org/10.1007/s00592-014-0601-3
  10. Ziegler D, Strom A, Bruggemann J, Ziegler I, Ringel B, Puttgen S et al. Overexpression of cutaneous mitochondrial superoxide dismutase in recentonset type 2 diabetes. Diabetologia 2015; 58: 1621-1625. https://doi.org/10.1007/s00125-015-3609-5
  11. Szendroedi J, Saxena A, Weber KS, Strassburger K, Herder C, Burkart V et al. Cohort profile: the German Diabetes Study (GDS). Cardiovasc Diabetol 2016; 15: 1-14. https://doi.org/10.1186/s12933-015-0324-y
  12. Ziegler D, Papanas N, Zhivov A, Allgeier S, Winter K, Ziegler I et al. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes 2014; 63: 2454-2463. https://doi.org/10.2337/db13-1819
  13. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154. https://doi.org/10.1007/BF00400697
  14. Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev 2011; 27: 620-628. https://doi.org/10.1002/dmrr.1226
  15. Jelenik T, Sequaris G, Kaul K, Ouwens DM, Phielix E, Kotzka J et al. Tissue-specific differences in the development of insulin resistance in a mouse model for Type 1 diabetes. Diabetes 2014; 63: 3856-3867. https://doi.org/10.2337/db13-1794
  16. Iida S, Chu Y, Francis J, Weiss RM, Gunnett CA, Faraci FM et al. Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure. Am J Physiol Heart Circ Physiol 2005; 289: H525-H532. https://doi.org/10.1152/ajpheart.00108.2005
  17. Kemp K, Gray E, Mallam E, Scolding N, Wilkins A. Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells. Stem Cell Rev 2010; 6: 548-559. https://doi.org/10.1007/s12015-010-9178-6
  18. Schamarek I, Herder C, Nowotny B, Carstensen-Kirberg M, Strassburger K, Nowotny P et al. Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes. Eur J Endocrinol 2016; 174: 433-443. https://doi.org/10.1530/EJE-15-1010
  19. Forsberg E, Xu C, Grunler J, Frostegard J, Tekle M, Brismar K et al. Coenzyme Q10 and oxidative stress, the association with peripheral sensory neuropathy and cardiovascular disease in type 2 diabetes mellitus. J Diab Complications 2015; 29: 1152-1158. https://doi.org/10.1016/j.jdiacomp.2015.08.006
  20. Schneider MP, Ritt M, Raff U, Ott C, Schmieder RE. Gender is related to alterations of renal endothelial function in type 2 diabetes. Nephrol Dial Transplant 2009; 24: 3354-3359. https://doi.org/10.1093/ndt/gfp318
  21. Kasznicki J, Kosmalski M, Sliwinska A, Mrowicka M, Stanczyk M, Majsterek I et al. Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy. Mol Biol Rep 2012; 39: 8669-8678. https://doi.org/10.1007/s11033-012-1722-9
  22. Mendez MM, Folgado J, Tormo C, Artero A, Ascaso M, Martinez-Hervas S et al. Altered glutathione system is associated with the presence of distal symmetric peripheral polyneuropathy in type 2 diabetic subjects. J Diab Complications 2015; 29: 923-927. https://doi.org/10.1016/j.jdiacomp.2015.05.023
  23. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998; 21: 1736-1742. https://doi.org/10.2337/diacare.21.10.1736
  24. Seghrouchni I, Drai J, Bannier E, Riviere J, Calmard P, Garcia I et al. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta 2002; 321: 89-96. https://doi.org/10.1016/S0009-8981(02)00099-2

피인용 문헌

  1. Ranirestat Improved Nerve Conduction Velocities, Sensory Perception, and Intraepidermal Nerve Fiber Density in Rats with Overt Diabetic Polyneuropathy vol.2019, pp.None, 2017, https://doi.org/10.1155/2019/2756020
  2. Circulating Oxidative Stress Biomarkers in Clinical Studies on Type 2 Diabetes and Its Complications vol.2019, pp.None, 2017, https://doi.org/10.1155/2019/5953685
  3. Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy vol.40, pp.1, 2017, https://doi.org/10.1210/er.2018-00107
  4. Oxidative stress markers in cognitively intact patients with diabetic neuropathy vol.150, pp.None, 2017, https://doi.org/10.1016/j.brainresbull.2019.06.001
  5. Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy vol.9, pp.10, 2020, https://doi.org/10.3390/antiox9100925
  6. Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy vol.12, pp.11, 2017, https://doi.org/10.3390/nu12113254
  7. Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)-New Aspects vol.22, pp.19, 2021, https://doi.org/10.3390/ijms221910835
  8. Association among extracellular superoxide dismutase genotype, plasma concentration, and comorbidity in the very old and centenarians vol.11, pp.1, 2021, https://doi.org/10.1038/s41598-021-87982-6
  9. Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia vol.874, pp.None, 2017, https://doi.org/10.1016/j.mrgentox.2021.503437